tetano
Editor, Senior Moderator
Vaccine
. 2021 Nov 29;S0264-410X(21)01257-3.
doi: 10.1016/j.vaccine.2021.09.054. Online ahead of print.
Effectiveness and cost-effectiveness of influenza vaccination for elderly people
Yoshiyuki Sugishita[SUP] 1 [/SUP], Tamie Sugawara[SUP] 2 [/SUP]
Affiliations
Abstract
For elderly people who have low incidence of influenza, calculation of credible vaccine effectiveness (VE) sometimes becomes difficult. Currently, VE for elderly people is insufficient to ascertain the precise efficacy specifically. Cost-effectiveness of influenza vaccination of elderly people is discussed widely in terms of topics and areas. This report describes research results demonstrating influenza vaccination effectiveness among elderly people based on recent findings. Newly available influenza vaccination for elderly people appears to be cost-effective compared with that of trivalent inactiveted influenza vaccine. Overall, for all influenza virus types, it remains unclear whether influenza vaccination shows high VE. A decreasing effect of repeated vaccination was confirmed partially by test negative design and a serological study of cohorts. However, some studies have found no such decreasing effect. Measurement of VE and subsequent analysis of the cost-effectiveness of influenza vaccination for elderly people requires long-term monitoring using serological studies and test negative design.
. 2021 Nov 29;S0264-410X(21)01257-3.
doi: 10.1016/j.vaccine.2021.09.054. Online ahead of print.
Effectiveness and cost-effectiveness of influenza vaccination for elderly people
Yoshiyuki Sugishita[SUP] 1 [/SUP], Tamie Sugawara[SUP] 2 [/SUP]
Affiliations
- PMID: 34857422
- DOI: 10.1016/j.vaccine.2021.09.054
Abstract
For elderly people who have low incidence of influenza, calculation of credible vaccine effectiveness (VE) sometimes becomes difficult. Currently, VE for elderly people is insufficient to ascertain the precise efficacy specifically. Cost-effectiveness of influenza vaccination of elderly people is discussed widely in terms of topics and areas. This report describes research results demonstrating influenza vaccination effectiveness among elderly people based on recent findings. Newly available influenza vaccination for elderly people appears to be cost-effective compared with that of trivalent inactiveted influenza vaccine. Overall, for all influenza virus types, it remains unclear whether influenza vaccination shows high VE. A decreasing effect of repeated vaccination was confirmed partially by test negative design and a serological study of cohorts. However, some studies have found no such decreasing effect. Measurement of VE and subsequent analysis of the cost-effectiveness of influenza vaccination for elderly people requires long-term monitoring using serological studies and test negative design.